UA112768C2 - Європейський штам prrsv - Google Patents
Європейський штам prrsvInfo
- Publication number
- UA112768C2 UA112768C2 UAA201310958A UAA201310958A UA112768C2 UA 112768 C2 UA112768 C2 UA 112768C2 UA A201310958 A UAA201310958 A UA A201310958A UA A201310958 A UAA201310958 A UA A201310958A UA 112768 C2 UA112768 C2 UA 112768C2
- Authority
- UA
- Ukraine
- Prior art keywords
- ecacc
- prrsv strain
- european
- european prrsv
- viruses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10061—Methods of inactivation or attenuation
- C12N2770/10064—Methods of inactivation or attenuation by serial passage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10071—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Винахід належить до вірусів репродуктивно-респіраторного синдрому свиней (PRRSV) європейського типу, який являє собою штами, депоновані в Європейській колекції клітинних культур (ECACC) під реєстраційними номерами ECACC 11012501 та ECACC 11012502. Винахід також стосується способу одержання живої ослабленої вакцини для боротьби з PRRS, яка містить заявлені віруси та саму вакцину.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA201607463A UA117272C2 (uk) | 2011-02-17 | 2012-02-14 | Новий європейський штам prrsv |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161444074P | 2011-02-17 | 2011-02-17 | |
PCT/EP2012/052475 WO2012110489A2 (en) | 2011-02-17 | 2012-02-14 | Novel european prrsv strain |
Publications (1)
Publication Number | Publication Date |
---|---|
UA112768C2 true UA112768C2 (uk) | 2016-10-25 |
Family
ID=45614840
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201607463A UA117272C2 (uk) | 2011-02-17 | 2012-02-14 | Новий європейський штам prrsv |
UAA201310958A UA112768C2 (uk) | 2011-02-17 | 2012-02-14 | Європейський штам prrsv |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201607463A UA117272C2 (uk) | 2011-02-17 | 2012-02-14 | Новий європейський штам prrsv |
Country Status (30)
Country | Link |
---|---|
US (4) | US8765142B2 (uk) |
EP (2) | EP2675475B1 (uk) |
JP (1) | JP5788027B2 (uk) |
KR (2) | KR102183276B1 (uk) |
CN (2) | CN106110318A (uk) |
AR (2) | AR085272A1 (uk) |
AU (2) | AU2012217169B2 (uk) |
BR (2) | BR112013021076B1 (uk) |
CA (1) | CA2826341C (uk) |
CL (1) | CL2013002379A1 (uk) |
CO (1) | CO6791570A2 (uk) |
CY (1) | CY1116835T1 (uk) |
DK (2) | DK2959916T3 (uk) |
EA (2) | EA038012B1 (uk) |
ES (2) | ES2692809T3 (uk) |
HR (1) | HRP20151031T1 (uk) |
HU (1) | HUE027731T2 (uk) |
ME (1) | ME02271B (uk) |
MX (2) | MX355058B (uk) |
MY (2) | MY186535A (uk) |
PH (1) | PH12017500962A1 (uk) |
PL (2) | PL2959916T3 (uk) |
PT (2) | PT2959916T (uk) |
RS (1) | RS54231B1 (uk) |
SG (1) | SG192820A1 (uk) |
SI (1) | SI2675475T1 (uk) |
SM (1) | SMT201500236B (uk) |
TW (2) | TWI665303B (uk) |
UA (2) | UA117272C2 (uk) |
WO (1) | WO2012110489A2 (uk) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2959916T3 (pl) | 2011-02-17 | 2019-05-31 | Boehringer Ingelheim Vetmedica Gmbh | Nowy europejski szczep prrsv |
JP2014506795A (ja) | 2011-02-17 | 2014-03-20 | ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング | Prrsvの工業規模の製造方法 |
US8906385B2 (en) | 2011-12-01 | 2014-12-09 | University Of Maryland, College Park | Interferon-inducing porcine reproductive and respiratory syndrome virus isolate |
CN105688201A (zh) * | 2012-05-17 | 2016-06-22 | 佐蒂斯有限责任公司 | 在断奶之前对抗猪繁殖与呼吸综合征(prrs)病毒的有效疫苗接种 |
US9314519B2 (en) | 2012-08-21 | 2016-04-19 | Intervet Inc. | Liquid stable virus vaccines |
US9457073B2 (en) | 2012-09-26 | 2016-10-04 | University Of Manitoba | Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity |
CN105308178B (zh) | 2012-12-07 | 2019-06-07 | 伊利诺伊大学评议会 | 猪繁殖与呼吸综合征病毒组合物及其用途 |
US9393298B2 (en) | 2013-03-15 | 2016-07-19 | Intervet Inc. | Liquid stable bovine virus vaccines |
US9480739B2 (en) | 2013-03-15 | 2016-11-01 | Intervet Inc. | Bovine virus vaccines that are liquid stable |
AR097762A1 (es) | 2013-09-27 | 2016-04-13 | Intervet Int Bv | Formulaciones secas de vacunas que son estables a temperatura ambiente |
CN105829528B (zh) * | 2013-12-20 | 2019-10-22 | 勃林格殷格翰动物保健有限公司 | PRRS病毒变体、欧洲PRRS病毒cDNA克隆及其用途 |
US10280199B2 (en) | 2014-02-07 | 2019-05-07 | Phibro Animal Health Corporation | Coronavirus proteins and antigens |
AR099470A1 (es) | 2014-02-17 | 2016-07-27 | Intervet Int Bv | Vacunas de virus de aves de corral líquidas |
TWI670085B (zh) * | 2014-02-19 | 2019-09-01 | 荷蘭商英特威國際公司 | 液體穩定之豬病毒疫苗 |
US11040059B2 (en) * | 2014-10-27 | 2021-06-22 | Pharmacosmos Holding A/S | Treatment or prevention of anaemia in pregnant non-human mammals |
CN106924726B (zh) * | 2015-12-29 | 2021-02-09 | 普莱柯生物工程股份有限公司 | 一种用于预防猪繁殖与呼吸综合征的疫苗组合物及其制备方法和应用 |
US10279031B2 (en) | 2016-05-11 | 2019-05-07 | Phibro Animal Health Corporation | Composition comprising antigens and a mucosal adjuvant and a method for using |
CA3022006A1 (en) * | 2016-05-11 | 2017-11-16 | Phibro Animal Health Corporation | A composition comprising antigens and a mucosal adjuvant and a method for using |
MX2019005136A (es) | 2016-11-03 | 2019-06-20 | Boehringer Ingelheim Vetmedica Gmbh | Vacuna contra el parvovirus porcino y el virus del sindrome respiratorio reproductivo porcino y metodos de produccion de esta. |
BR112019012158A2 (pt) * | 2016-12-14 | 2019-11-12 | Zoetis Services Llc | vacinação eficaz contra cepas europeias de vírus da síndrome reprodutiva e respiratória suína (prrs) antes do desmame |
US11013796B2 (en) | 2018-08-30 | 2021-05-25 | Iowa State University Research Foundation, Inc. | Porcine parainfluenza virus type 1 isolates and immunogenic compositions therefrom |
WO2020206452A1 (en) | 2019-04-04 | 2020-10-08 | Boehringer Ingelheim Animal Health USA Inc. | Porcine circovirus type 3 (pcv3) vaccines, and production and uses thereof |
CN110735005B (zh) * | 2019-11-26 | 2023-01-10 | 广西大学 | Siv和prrsv多重rt-pcr快速检测试剂盒及引物 |
CN111676247A (zh) * | 2020-06-30 | 2020-09-18 | 扬州大学 | 一株猪繁殖与呼吸综合征病毒1型分离株感染性克隆构建、拯救与应用 |
US20230241198A1 (en) | 2020-07-24 | 2023-08-03 | Boehringer Ingelheim Animal Health USA Inc. | Combination porcine vaccine |
CN113862230B (zh) * | 2021-09-30 | 2023-08-08 | 中牧实业股份有限公司 | 一种猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用 |
Family Cites Families (113)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE148705C (uk) | ||||
US3137631A (en) | 1959-12-01 | 1964-06-16 | Faberge Inc | Encapsulation in natural products |
US3080291A (en) | 1960-06-10 | 1963-03-05 | Jensen Salsberg Lab Inc | Serial passage of distemper virus in tissue cultures of chick embryo and canine tissue and vaccine therefrom |
US3959457A (en) | 1970-06-05 | 1976-05-25 | Temple University | Microparticulate material and method of making such material |
US4015100A (en) | 1974-01-07 | 1977-03-29 | Avco Everett Research Laboratory, Inc. | Surface modification |
US4122167A (en) | 1977-02-09 | 1978-10-24 | Merck & Co., Inc. | Respiratory synctial vaccine |
US4205060A (en) | 1978-12-20 | 1980-05-27 | Pennwalt Corporation | Microcapsules containing medicament-polymer salt having a water-insoluble polymer sheath, their production and their use |
US4224412A (en) | 1979-05-01 | 1980-09-23 | Dorofeev Viktor M | Living virus culture vaccine against canine distemper and method of preparing same |
US4554159A (en) | 1981-11-12 | 1985-11-19 | Institute Merieux | Vaccine and method of immunizing against herpes simplex virus (types 1 and 2) |
US4452747A (en) | 1982-03-22 | 1984-06-05 | Klaus Gersonde | Method of and arrangement for producing lipid vesicles |
GB8319302D0 (en) | 1983-07-16 | 1983-08-17 | Tpt Ltd | Container |
US4468346A (en) | 1983-10-27 | 1984-08-28 | The United States Of America As Represented By The Secretary Of Agriculture | Monoclonal antibodies to porcine immunoglobulins |
DE3405100A1 (de) | 1984-02-14 | 1985-08-14 | Drägerwerk AG, 2400 Lübeck | Pt-katalysator auf einem traeger als luftreinigungsmittel |
US4744933A (en) | 1984-02-15 | 1988-05-17 | Massachusetts Institute Of Technology | Process for encapsulation and encapsulated active material system |
US5008050A (en) | 1984-06-20 | 1991-04-16 | The Liposome Company, Inc. | Extrusion technique for producing unilamellar vesicles |
US4921706A (en) | 1984-11-20 | 1990-05-01 | Massachusetts Institute Of Technology | Unilamellar lipid vesicles and method for their formation |
US4606940A (en) | 1984-12-21 | 1986-08-19 | The Ohio State University Research Foundation | Small particle formation and encapsulation |
DE3687769T2 (de) | 1985-07-08 | 1993-09-02 | Chiron Corp | Vakzine und diagnostika, die vom bovine-diarrhea-virus stammen. |
US5206163A (en) | 1985-07-08 | 1993-04-27 | Chiron Corporation | DNA encoding bovine diarrhea virus protein |
US4753884A (en) | 1986-01-28 | 1988-06-28 | Novagene, Inc. | Pseudorabies virus mutants, vaccines containing same, methods for the production of same and methods for the use of same |
JPS62198626A (ja) | 1986-02-26 | 1987-09-02 | Biseibutsu Kagaku Kenkyusho:Kk | 血球凝集性脳脊髄炎ウイルス感染症予防ワクチン |
FR2602791B1 (fr) | 1986-08-18 | 1988-11-10 | Ministere Agri Direction Quali | Procede de culture du virus de la rhinotracheite infectieuse de la dinde, et vaccin prepare a partir du virus ainsi obtenu |
NZ222465A (en) | 1986-11-07 | 1992-11-25 | Pasteur Institut | Nanb (non a, non b hepatitis viral) antigen |
US5009956A (en) | 1987-02-24 | 1991-04-23 | Univ Minnesota | Phospholipase A2-resistant liposomes |
DE3833925A1 (de) | 1988-03-11 | 1989-09-21 | Inst Angewandte Biotechnologie | Verfahren und herstellung von virus und viralem antigen und vorrichtung hierzu |
US5213759A (en) | 1988-05-05 | 1993-05-25 | Elopak Systems A.G. | Sterilization |
US4927637A (en) | 1989-01-17 | 1990-05-22 | Liposome Technology, Inc. | Liposome extrusion method |
US4944948A (en) | 1989-02-24 | 1990-07-31 | Liposome Technology, Inc. | EGF/Liposome gel composition and method |
US5132117A (en) | 1990-01-11 | 1992-07-21 | Temple University | Aqueous core microcapsules and method for their preparation |
AU7007491A (en) | 1990-02-02 | 1991-08-08 | Schweiz. Serum- & Impfinstitut Bern | Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses |
DE69201441T3 (de) | 1991-06-06 | 2008-12-04 | Boehringer Ingelheim Vetmedica Gmbh | Erreger der mysteriösen schweinekrankheit,impfstoff-zusammensetzungen und diagnose kits. |
DK0601062T4 (da) | 1991-08-26 | 2001-03-14 | Univ Minnesota | SIRS-vaccine og diagnosefremgangsmåde |
US5846805A (en) | 1991-08-26 | 1998-12-08 | Boehringer Ingelheim Animal Health, Inc. | Culture of swine infertility and respiratory syndrome virus in simian cells |
CA2076744C (en) | 1991-08-26 | 2000-06-27 | Danny W. Chladek | Viral agent associated with mystery swine disease |
US6982160B2 (en) | 1991-08-26 | 2006-01-03 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions that include SIRS virus |
US6080570A (en) | 1991-08-26 | 2000-06-27 | Boehringer Ingelheim Vetmedica, Inc. | Method of producing a vaccine for Swine Infertility and Respiratory Syndrome |
US6042830A (en) * | 1992-08-05 | 2000-03-28 | Boehringer Ingelheim Vetmedica, Inc. | Viral agent associated with mystery swine disease |
AU2696792A (en) | 1991-09-16 | 1993-04-27 | David A Benfield | Vaccine for mystery swine disease and method for diagnosis thereof |
ATE131067T1 (de) | 1991-10-14 | 1995-12-15 | Akzo Nobel Nv | Impfstoff gegen das fortpflanzungs- und atmungssyndrom bei schweinen (prrs) und diagnose. |
FR2686097B1 (fr) | 1992-01-14 | 1994-12-30 | Rhone Merieux | Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie. |
US5338543A (en) | 1992-02-27 | 1994-08-16 | Ambico, Inc. | Thimerosal inactivated mycoplasma hyopneumoniae vaccine |
TW289731B (uk) | 1992-07-09 | 1996-11-01 | Akzo Nv | |
US6380376B1 (en) | 1992-10-30 | 2002-04-30 | Iowa State University Research Foundation | Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
US6592873B1 (en) | 1992-10-30 | 2003-07-15 | Iowa State University Research Foundation, Inc. | Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids |
US6773908B1 (en) | 1992-10-30 | 2004-08-10 | Iowa State University Research Foundation, Inc. | Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
US6251397B1 (en) | 1992-10-30 | 2001-06-26 | Iowa State University Research Foundation, Inc. | Proteins encoded by polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus and immunogenic compositions containing the same |
US5695766A (en) | 1992-10-30 | 1997-12-09 | Iowa State University Research Foundation | Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome |
US5419907A (en) | 1992-11-10 | 1995-05-30 | Iowa State University Research Foundation, Inc. | Pathogenic porcine respiratory coronavirus |
KR100374295B1 (ko) | 1993-02-08 | 2003-12-24 | 바이엘 코포레이션 | 돼지생식및호흡증후군바이러스의생육방법과백신에서그의용도 |
ES2074950B1 (es) | 1993-09-17 | 1996-03-16 | Iberica Cyanamid | Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda. |
EP0659885A1 (en) | 1993-12-21 | 1995-06-28 | Akzo Nobel N.V. | Vaccine against viruses associated with antibody-dependent-enhancement of viral infectivity |
DE4407489A1 (de) | 1994-03-07 | 1995-09-14 | Bayer Ag | Vakzine zur Prävention von Respirations- und Reproduktionserkrankungen des Schweines |
PT676467E (pt) | 1994-04-11 | 2002-02-28 | Akzo Nobel Nv | Estirpes europeias de vacina do virus do sindroma reprodutivo e respiratorio porcino (prrsv) |
ATE235959T1 (de) | 1994-04-15 | 2003-04-15 | Univ Temple | Methode zum einkapseln mittels eines wässrigen lösungsmittels und mikrokapseln |
GB2289279B (en) | 1994-05-13 | 1998-09-16 | Iberica Cyanamid | Diagnostic kits and vaccines containing recombinant PRRSV proteins |
WO1996004010A1 (en) | 1994-08-05 | 1996-02-15 | Regents Of The University Of Minnesota | Vr-2332 viral nucleotide sequence and methods of use |
DK0732340T3 (da) | 1995-03-14 | 2004-10-25 | Akzo Nobel Nv | Ekspression af porcine reproduktions- og respirationssyndromviruspolypeptider i den samme celle |
US5690940A (en) | 1995-06-21 | 1997-11-25 | Regents Of The University Of Minnesota | Low pathogencity PRRS live virus vaccines and methods of preparation thereof |
ES2102971B1 (es) | 1996-01-25 | 1998-03-01 | Hipra Lab Sa | Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion. |
US6015663A (en) | 1996-03-01 | 2000-01-18 | The United States Of America As Represented By The Secretary Of Agriculture | Restriction enzyme screen for differentiating porcine reproductive and respiratory syndrome virus strains |
US5866401A (en) | 1996-03-01 | 1999-02-02 | Schering Corporation | Porcine reproductive and respiratory syndrome vaccine |
MY115070A (en) | 1996-03-01 | 2003-03-31 | Schering Corp | Porcine reproductive and respiratory syndrome vaccine |
US5976537A (en) | 1996-07-02 | 1999-11-02 | The United States Of America As Represented By The Secretary Of Agriculture | Porcine reproductive and respiratory syndrome vaccine |
DK0835930T3 (da) | 1996-10-09 | 2001-06-18 | Akzo Nobel Nv | Europæiske vaccinestammer af porcint reproduktions- og respirationssyndrom-virus. (PRRSV) |
US20040224327A1 (en) | 1996-10-30 | 2004-11-11 | Meulenberg Johanna Jacoba Maria | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
EP0839912A1 (en) | 1996-10-30 | 1998-05-06 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
WO1998035023A1 (en) * | 1997-02-07 | 1998-08-13 | Origen, Inc. | Method for growing porcine reproductive and respiratory syndrome virus for use as vaccines and diagnostic assays |
CA2703181C (en) | 1997-05-06 | 2016-06-28 | Boehringer Ingelheim Vetmedica Gmbh | Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays |
WO1998055625A1 (en) | 1997-06-04 | 1998-12-10 | Calgene, Llc | Production of polyunsaturated fatty acids by expression of polyketide-like synthesis genes in plants |
AU7960598A (en) | 1997-06-05 | 1998-12-21 | Origen, Inc. | Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine |
US6391314B1 (en) | 1997-10-03 | 2002-05-21 | Merial | Porcine circoviruses vaccines diagnostic reagents |
US7211379B2 (en) | 1997-10-03 | 2007-05-01 | Merial Sas | Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2 |
CA2440933A1 (en) | 1998-12-22 | 2000-06-22 | Pfizer Products Inc. | An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof |
US7691389B2 (en) | 1998-12-22 | 2010-04-06 | Pfizer Inc | Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US7132106B2 (en) | 1998-12-22 | 2006-11-07 | Pfizer Inc. | Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
US7618797B2 (en) | 1998-12-22 | 2009-11-17 | Pfizer Inc | Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
FR2789695B1 (fr) | 1999-02-11 | 2003-03-07 | Merial Sas | Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs |
CA2366072C (en) | 1999-03-08 | 2007-07-10 | Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. | Prrsv vaccines |
AU4482200A (en) | 1999-04-22 | 2000-11-10 | United States Department Of Agriculture | Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142 |
US20040213805A1 (en) | 1999-10-12 | 2004-10-28 | Verheije Monique Helene | Deletions in arterivirus replicons |
US20020012670A1 (en) | 2000-01-26 | 2002-01-31 | Knut Elbers | Recombinant attenuation of porcine reproductive and respiratory syndrome (PRRSV) |
DE60121545T2 (de) | 2000-02-08 | 2007-06-28 | Regents Of The University Of Minnesota, Minneapolis | Virus des porcinen reproduktiven und respiratorischen syndroms und dessen verwendung |
EP1156111A1 (en) | 2000-05-19 | 2001-11-21 | Stichting Dienst Landbouwkundig Onderzoek | Chimeric arterivirus-like particles |
US7018638B2 (en) | 2000-12-19 | 2006-03-28 | Wyeth | Mycoplasma hyopneumoniae bacterin vaccine |
BR0207988A (pt) * | 2001-03-09 | 2004-10-26 | Boehringer Ingelheim Vetmed | Cepas atenuadas vivas de vìrus de prrs |
EP1397498A1 (en) | 2001-05-21 | 2004-03-17 | ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. | Delections in arterivirus replicons |
US7279166B2 (en) | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
US6841364B2 (en) | 2002-01-22 | 2005-01-11 | Protatek International, Inc. | Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof |
ATE557082T1 (de) | 2002-04-05 | 2012-05-15 | Boehringer Ingelheim Vetmed | Sequenz positionen zur anpassung bei prrsv |
US7335361B2 (en) | 2003-06-09 | 2008-02-26 | Animal Technology Institute Taiwan | Fusion antigen used as vaccine |
US7722878B2 (en) | 2004-06-17 | 2010-05-25 | Boehringer Ingelheim Vetmedica, Inc. | PRRSV subunit vaccines |
CN101039693A (zh) * | 2004-06-18 | 2007-09-19 | 明尼苏达大学董事会 | 鉴定病毒感染和疫苗接种的生物 |
CA2571452A1 (en) | 2004-06-18 | 2006-01-26 | Regents Of The University Of Minnesota | Identifying virally infected and vaccinated organisms |
US7632636B2 (en) | 2004-09-21 | 2009-12-15 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome isolates and methods of use |
US20060063151A1 (en) | 2004-09-21 | 2006-03-23 | Michael Roof | Porcine reproductive and respiratory syndrome isolates and methods of use |
BRPI0517745A (pt) * | 2004-11-11 | 2008-10-21 | Pfizer Prod Inc | vìrus mutante da sìndrome reprodutiva e respiratória de suìnos |
KR101152012B1 (ko) * | 2004-11-19 | 2012-07-04 | 인터벳 인터내셔널 비.브이. | 돼지 생식기 및 호흡기 증후군 바이러스 균주 및 조성물 |
RU2007130801A (ru) | 2005-01-13 | 2009-02-20 | Берингер Ингельхайм Ветмедика Гмбх (De) | Улучшенные вакцины против репродуктивно-респираторного синдрома свиней (prrs) |
UA95778C2 (uk) | 2005-06-24 | 2011-09-12 | Риджентс Оф Зе Юниверсити Оф Миннесота | Віруси репродуктивно-респіраторного синдрому свиней, їх інфекційні клони та мутанти та способи застосування |
US7622254B2 (en) * | 2005-11-29 | 2009-11-24 | Iowa State University Research Foundation, Inc. | Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus and uses thereof |
US8563313B2 (en) * | 2007-02-13 | 2013-10-22 | Washington State University Research Foundation | Macrophage cell-lines for propagation of porcine reproductive and respiratory syndrome virus |
WO2008121958A1 (en) | 2007-04-02 | 2008-10-09 | Boehringer Ingelheim Vetmedica, Inc. | Use of prrsv vaccines to reduce pcv2 viremia |
US20100003278A1 (en) | 2008-07-03 | 2010-01-07 | Boehringer Ingelheim Vetmedica, Inc. | Immunological Compositions Effective for Lessening the Severity or Incidence of PRRSV Signs and Methods of Use Thereof |
RU2561595C2 (ru) | 2008-08-25 | 2015-08-27 | Бёрингер Ингельхайм Ветмедика, Инк. | Вакцина против высокопатогенного репродуктивно-респираторного синдрома свиней (hp prrs) |
US20100129398A1 (en) | 2008-11-26 | 2010-05-27 | Boehringer Ingelheim Vetmedica, Inc. | Materials and Methods for Control of Porcine Reproductive and Respiratory Syndrome |
EP2558118B1 (en) | 2010-04-16 | 2019-06-05 | Universiteit Gent | Cross-protecting vaccine for porcine reproductive and respiratory syndrome virus |
CN101920010A (zh) * | 2010-06-29 | 2010-12-22 | 西北农林科技大学 | 表达prrsv免疫原基因的重组减毒鼠伤寒沙门氏菌载体疫苗及其制备方法 |
US8728487B2 (en) | 2011-01-20 | 2014-05-20 | Hua Wu | Attenuated live vaccine for prevention of porcine reproductive and respiratory syndrome |
JP2014506795A (ja) * | 2011-02-17 | 2014-03-20 | ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング | Prrsvの工業規模の製造方法 |
PL2959916T3 (pl) | 2011-02-17 | 2019-05-31 | Boehringer Ingelheim Vetmedica Gmbh | Nowy europejski szczep prrsv |
EP2737059A1 (en) | 2011-07-29 | 2014-06-04 | Boehringer Ingelheim Vetmedica GmbH | Novel prrs virus inducing type i interferon in susceptible cells |
US9579373B2 (en) | 2013-03-15 | 2017-02-28 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use |
CN105829528B (zh) | 2013-12-20 | 2019-10-22 | 勃林格殷格翰动物保健有限公司 | PRRS病毒变体、欧洲PRRS病毒cDNA克隆及其用途 |
-
2012
- 2012-02-14 PL PL15174330T patent/PL2959916T3/pl unknown
- 2012-02-14 UA UAA201607463A patent/UA117272C2/uk unknown
- 2012-02-14 ME MEP-2015-135A patent/ME02271B/me unknown
- 2012-02-14 EP EP12704409.7A patent/EP2675475B1/en active Active
- 2012-02-14 PL PL12704409T patent/PL2675475T3/pl unknown
- 2012-02-14 US US13/396,298 patent/US8765142B2/en active Active
- 2012-02-14 HU HUE12704409A patent/HUE027731T2/en unknown
- 2012-02-14 SI SI201230296T patent/SI2675475T1/sl unknown
- 2012-02-14 DK DK15174330.9T patent/DK2959916T3/en active
- 2012-02-14 KR KR1020207002718A patent/KR102183276B1/ko active IP Right Grant
- 2012-02-14 WO PCT/EP2012/052475 patent/WO2012110489A2/en active Application Filing
- 2012-02-14 UA UAA201310958A patent/UA112768C2/uk unknown
- 2012-02-14 EP EP15174330.9A patent/EP2959916B1/en active Active
- 2012-02-14 RS RS20150614A patent/RS54231B1/en unknown
- 2012-02-14 CN CN201610479980.7A patent/CN106110318A/zh active Pending
- 2012-02-14 DK DK12704409.7T patent/DK2675475T3/en active
- 2012-02-14 MX MX2016014357A patent/MX355058B/es unknown
- 2012-02-14 PT PT15174330T patent/PT2959916T/pt unknown
- 2012-02-14 PT PT127044097T patent/PT2675475E/pt unknown
- 2012-02-14 SG SG2013062468A patent/SG192820A1/en unknown
- 2012-02-14 CN CN201280009228.6A patent/CN103370078B/zh active Active
- 2012-02-14 CA CA2826341A patent/CA2826341C/en active Active
- 2012-02-14 ES ES15174330.9T patent/ES2692809T3/es active Active
- 2012-02-14 BR BR112013021076-1A patent/BR112013021076B1/pt active IP Right Grant
- 2012-02-14 MX MX2013009485A patent/MX345188B/es active IP Right Grant
- 2012-02-14 EA EA201692359A patent/EA038012B1/ru unknown
- 2012-02-14 EA EA201300915A patent/EA035624B1/ru not_active IP Right Cessation
- 2012-02-14 KR KR1020137024630A patent/KR102073075B1/ko active IP Right Grant
- 2012-02-14 JP JP2013553905A patent/JP5788027B2/ja active Active
- 2012-02-14 MY MYPI2016001818A patent/MY186535A/en unknown
- 2012-02-14 AU AU2012217169A patent/AU2012217169B2/en active Active
- 2012-02-14 ES ES12704409.7T patent/ES2550258T3/es active Active
- 2012-02-14 BR BR122021013826-5A patent/BR122021013826B1/pt active IP Right Grant
- 2012-02-14 MY MYPI2013003032A patent/MY161198A/en unknown
- 2012-02-16 TW TW101105138A patent/TWI665303B/zh active
- 2012-02-16 AR ARP120100538A patent/AR085272A1/es active Pending
- 2012-02-16 TW TW105122637A patent/TWI673362B/zh active
-
2013
- 2013-08-16 CL CL2013002379A patent/CL2013002379A1/es unknown
- 2013-08-22 CO CO13199500A patent/CO6791570A2/es not_active Application Discontinuation
-
2014
- 2014-05-19 US US14/281,287 patent/US9534207B2/en active Active
-
2015
- 2015-09-29 HR HRP20151031TT patent/HRP20151031T1/hr unknown
- 2015-09-29 CY CY20151100866T patent/CY1116835T1/el unknown
- 2015-09-29 SM SM201500236T patent/SMT201500236B/xx unknown
-
2016
- 2016-07-15 AU AU2016204983A patent/AU2016204983B2/en active Active
- 2016-11-22 US US15/358,288 patent/US10039821B2/en active Active
-
2017
- 2017-05-25 PH PH12017500962A patent/PH12017500962A1/en unknown
-
2018
- 2018-06-28 US US16/021,543 patent/US10668144B2/en active Active
-
2019
- 2019-12-30 AR ARP190103882A patent/AR117530A2/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA112768C2 (uk) | Європейський штам prrsv | |
MX2021006342A (es) | Mutantes de virus de influenza y usos para los mismos. | |
EA201890942A1 (ru) | Мультивалентные вакцины с синтетическими наноносителями | |
TN2013000485A1 (en) | 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group | |
MD4589C1 (ro) | Compoziţie farmaceutică cu conţinut de sofosbuvir şi utilizarea acesteia în tratamentul hepatitei virale C | |
MX2013002173A (es) | Formas farmaceuticas dirigidas de epitopos multiples para la induccion de una respuesta inmunologica frente a antigenos. | |
MX356210B (es) | Formulaciones de polimero acrilico. | |
MX346596B (es) | Oligodesoxinucleotidos inmunoestimuladores. | |
NZ603863A (en) | Concentration and lyophilization of influenza vaccine antigens | |
MX2014010482A (es) | Metodo para la preparacion de vacunas de celulas dendriticas. | |
BR112014002173A2 (pt) | proteínas purificadas | |
BR112015008824A2 (pt) | linhagens melhoradas de microalgas e processo das mesmas | |
EA201590503A1 (ru) | Альфа-1-микроглобулин для применения в лечении заболеваний, связанных с митохондриями | |
IN2013MN00733A (uk) | ||
GB201122408D0 (en) | Method for preparing dry protein formulations | |
EA201300916A1 (ru) | Способ получения prrsv в коммерческом масштабе | |
MX2014007555A (es) | Proceso para la preparacion de magnolol y derivados del mismo. | |
MX350718B (es) | Vacuna de rinitis equina. | |
EA201590782A1 (ru) | Оксирановые амины | |
TH137303B (th) | สายพันธุ์ prrsv ยุโรปใหม่" | |
TH137303A (th) | สายพันธุ์ prrsv ยุโรปใหม่ | |
EA201201620A1 (ru) | Способ получения рнк-вируса | |
EP2501405A4 (en) | COMPOSITION, METHOD, AND USES OF POX VIRUS ELEMENTS IN VACCINATE CONSTRUCTS | |
RU2011111098A (ru) | Штамм trichoderma harzianum rifai - продуцент ингибитора вируса кольцевой пятнистости табака (tobacco ringspot virus) | |
MX354325B (es) | Método para preparar conjugados glucïdicos de glicopéptidos antigénicos múltiples. |